References:

[1]Ying Li,Gaichao Hong,Min Yang, et al. Fecal bacteria can predict the efficacy of rifaximin in patients with diar- rhea - predominant irritable bowel syndrome[J]. Pharma- cological Research,2020,159:104936.
[2]Gupta K,Ghuman HS. Review of Rifaximin: Latest Treat- ment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile[ J]. Clinical medicine insights Gastroenterology,2017,10:117955221772890.
[3]Lam Ching,Tan Wei,Leighton Matthew,et al. A mecha- nistic multicentre, parallel group, randomised placebo - controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS - D). [J]. Gut,2016,65(1).
[4]Joyce K. Anastasi,Bernadette Capili,Michelle Chang. De- velopment of Acupuncture and Moxibustion Protocol in a Clinical Trial for Irritable Bowel Syndrome[J]. Journal of Acupuncture and Meridian Studies,2017,10(1)62-66.
[5]储浩然,李难,程红亮. 温针灸治疗肝郁脾虚型肠易激 综合征疗效观察[ J]. 上海针灸杂志,2015,34 ( 5 ): 424-425.
[6]储浩然,吴立斌,程红亮,等. 艾灸对腹泻型肠易激综合 征模型大鼠血清白细胞介素 - 6 水平和结肠组织 β - 防御素 - 2 及其 mRNA 表达的影响[ J]. 安徽中医药大学报,2018,37(1):36-40.
[7]李倩,戴桃李,韩炜,等. 血管内皮细胞活化在感染后肠 易激综合征发病机制中的作用[ J]. 山东大学学报(医 学版),2016,54(12):58-61 + 66.
[8]Najjar Sarah A,Davis Brian M,Albers Kathryn M. Epithe- lial - Neuronal Communication in the Colon: Implications for Visceral Pain. [ J]. Trendsinneurosciences,2020,43 (3):170-181.
[9]唐洪梅,廖小红,房财富,等. 肝郁脾虚型大鼠肠易激综 合征模型的建立及评价[ J]. 中国实验方剂学杂志, 2012,18(6):138-140.
[10]任培培,汪龙德,刘俊宏,等. 腹泻型肠易激综合征肝 郁脾虚型病证结合大鼠模型的研究方法[ J]. 中医研 究,2019,32(6):49-52.
[11]齐琳婧,苏同生,刘志顺,等. 针刺曲池上巨虚治疗功 能 性 肠 病 临 床 观 察 [ J ]. 陕 西 药 医, 2014, 35 (2):224-225.
[12]储浩然,吴立斌,李难,等. 艾灸天枢、上巨虚治疗腹泻 型肠易激综合征的临床与动物实验研究[A]. 中国针 灸学会. 2017 世界针灸学术大会暨 2017 中国针灸学会 年会论文集[C]. 中国针灸学会:中国针灸会,2017:1.
[13]张艳佶,杨丹,陈祥林,等. 基于数据挖掘的针灸治疗 腹泻型肠易激综合征的取穴规律研究[ J]. 时珍国药, 2020,31(4):990-993.
[14]Xiaomei Wang,Qin Qi,Yuanyuan Wang,et al. Gut mi- crobiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome[J]. BioMed Central,2018, 13(1).
[15]张夏菲,陈超,韩娟,等. 艾烟有效性及安全性机制的 研究进展[J]. 陕西中医药大学报,2020,(3):096-100.
[16]KoC,ak E,Akbal E,K?klü S,et al. The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients withIrritable Bowel Syndrome[J]. Internal medicine ,2016,55 (9):1043-1048.
[17]Baranipour Saeed,Amini Kadijani Azade,Qujeq Durdi,et al. Inducible nitric oxide synthase as a potential blood - based biomarker in inflammatory bowel diseases. [ J ]. Gastroenterology and hepatology from bed to bench,2018, 11(Suppl 1):S124-S128.
[18]Jang Da Eun,Bae Ji Hyun,Chang Yoo Jin,et al. Neuro- nal Nitric Oxide Synthase Is a Novel Biomarker for the In- terstitial Cells of Cajal in Stress - Induced Diarrhea - Dominant Irritable Bowel Syndrome. [J]. Digestive disea- ses and sciences,2018,63(3).
[19]王陆军,于岩瀑,高树中,等. 脐疗对 IBS - D 模型大鼠 结肠 TRPV 受体表达影响的实验研究[ J]. 时珍国医国 药,2015,26(11):2807-2810.
[20]韩磊,李艺,郭广进,等. 模拟腰椎旋转手法抑制瞬时 感受器电位离子通道香草素受体 4 / 一氧化氮疼痛转 导通路 的 作 用 研 究 [ J ]. 安 徽 医 药, 2020, 24 ( 4 ): 677-680.
[21] 张蓓,袁凤娟,洪煜鹏,等. 金仁陈子方对 IBS 模型大鼠的治疗作用及机理研究[ J]. 中药新药与临床药理,2014,25(2):149-152